🇺🇸 FDA

Intelligence · Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda — grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≤24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months — use filters for patent-cliff planning.

Page 14 of 30

  1. US 9045496

    N-substituted oxazinopteridines and oxazinopteridinones

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9045436

    Heterocyclic compound and use thereof

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9040522

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9028809

    Compositions, methods and uses for expression of enterobacterium-associated peptides

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9029536

    Fused heterocyclic compounds

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9029388

    Condensed heterocyclic compound

    Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9023858

    Substituted pyrido[2,3-d]pyrimidines as delta-5-desaturase inhibitors

    Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9018175

    3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives

    Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9018374

    Crystal of amide compound

    Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9012447

    5-HT3 receptor antagonists

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9011926

    Method for producing granules

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9011874

    Compositions, methods and uses for poxvirus elements in vaccine constructs

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9005632

    Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9006201

    Prophylactic or therapeutic agent for diabetes

    Expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8993598

    Pyrrole compounds

    Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8980902

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8980322

    Controlled release composition

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8980275

    Targeted heterologous antigen presentation on calicivirus virus-like particles

    Expires Mon Mar 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8969387

    Pyrrole compounds

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8968996

    Compositions and methods for rapid immunization against dengue virus

    Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8957070

    Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8957069

    Benzofuran derivatives

    Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8952185

    Production method of optically active dihydrobenzofuran derivative

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8940758

    Fused heterocyclic compounds

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8937055

    Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating action

    Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8932853

    Method for manufacturing pancreatic-hormone-producing cells

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8933105

    Pyrrole compounds

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8933069

    Heterocyclic compound

    Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8927718

    Fused heterocyclic ring derivative and use thereof

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8926969

    Anti-CD38 antibodies

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8927016

    Producing a sustained-release preparation

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8927557

    Methylpyrrolopyrimidinecarboxamides

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8920812

    Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8921358

    Apoptosis signal-regulating kinase 1 inhibitors

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8921379

    Fused ring compound and use thereof

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8920840

    Enteric tablet

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8921354

    Heterocyclic compound

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8921326

    Sustained-release composition and method for producing the same

    Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8916566

    Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8916549

    Thienooxazepine derivative

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8916551

    Heterocyclic compound and use thereof

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8906411

    Pre-compacted calcium-containing compositions

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8906901

    Administration of dipeptidyl peptidase inhibitors

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8907089

    Fused heterocyclic ring derivative and use thereof

    Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8901309

    Fused triazoles for the treatment or prophylaxis of mild cognitive impairment

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8901171

    Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8901141

    Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8900638

    Solid preparation comprising alogliptin and metformin hydrochloride

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.